News | March 07, 2024
Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)